Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Lymphatic Abnormalities
×
90 days
×
Clear all
Filters
2
NCT05948943
2026-04-14
EPIK-L1
Novartis
Phase 2/3
Recruiting
232 enrolled
NCT06239480
2026-03-27
SELVA
Palvella Therapeutics, Inc.
Phase 3
Active not recruiting
51 enrolled
NCT05983159
2026-02-19
TARGET-VM
Murdoch Childrens Research Institute
Phase 2
Recruiting
50 enrolled